Substituents on Etoposide That Interact with Human Topoisomerase IIα in the Binary Enzyme−Drug Complex: Contributions to Etoposide Binding and Activity
- 21 March 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 47 (15), 4501-4509
- https://doi.org/10.1021/bi702019z
Abstract
Etoposide is a widely prescribed anticancer agent that stabilizes topoisomerase II-mediated DNA strand breaks. The drug contains a polycyclic ring system (rings A−D), a glycosidic moiety at C4, and a pendant ring (E-ring) at C1. A recent study that focused on yeast topoisomerase II demonstrated that the H15 geminal protons of the etoposide A-ring, the H5 and H8 protons of the B-ring, and the H2′, H6′, 3′-methoxyl, and 5′-methoxyl protons of the E-ring contact topoisomerase II in the binary enzyme−drug complex [Wilstermann et al. (2007) Biochemistry46, 8217–8225]. No interactions with the C4 sugar were observed. The present study used DNA cleavage assays, saturation transfer difference [1H] NMR spectroscopy, and enzyme−drug binding studies to further define interactions between etoposide and human topoisomerase IIα. Etoposide and three derivatives that lacked the C4 sugar were analyzed. Except for the sugar, 4′-demethyl epipodophyllotoxin is identical to etoposide, epipodophyllotoxin contains a 4′-methoxyl group on the E-ring, and 6,7-O,O-demethylenepipodophyllotoxin replaces the A-ring with a diol. Results suggest that etoposide−topoisomerase IIα binding is driven by interactions with the A- and B-rings and potentially by stacking interactions with the E-ring. We propose that the E-ring pocket on the enzyme is confined, because the addition of bulk to this ring adversely affects drug function. The A- and E-rings do not appear to contact DNA in the enzyme–drug–DNA complex. Conversely, the sugar moiety subtly alters DNA interactions. The identification of etoposide substituents that contact topoisomerase IIα in the binary complex has predictive value for drug behavior in the enzyme−etoposide−DNA complex.Keywords
This publication has 82 references indexed in Scilit:
- Topoisomerase II−Drug Interaction Domains: Identification of Substituents on Etoposide That Interact with the EnzymeBiochemistry, 2007
- Functional compatibility between isoform α and β of type II DNA topoisomeraseJournal of Cell Science, 2004
- Characterization of Ligand Binding by Saturation Transfer Difference NMR SpectroscopyAngewandte Chemie-International Edition, 1999
- Essential Mitotic Functions of DNA Topoisomerase IIα Are Not Adopted by Topoisomerase IIβ in Human H69 CellsPublished by Elsevier BV ,1998
- DNA topoisomerase II mutations and resistance to anti‐tumor drugsBioEssays, 1995
- Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20European Journal of Cancer, 1993
- Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase IIBiochemistry, 1991
- Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposideEuropean Journal of Cancer and Clinical Oncology, 1990
- Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell lineBiochemistry, 1989
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984